跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BRIMICA GENUAIR 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler - TGA Drug Approval Details
Approvals
/
TGA
/
BRIMICA GENUAIR 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler
Approved
STANDARD
BRIMICA GENUAIR 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler
A Menarini Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
67565aa4e27a3d7f
Company
A Menarini Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
67565aa4e27a3d7f
Product Name
BRIMICA GENUAIR 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler
Artg Id
224899
Artg Name
BRIMICA GENUAIR 340/12 aclidinium bromide and formoterol fumarate dihydrate powder for inhalation dry powder inhaler
Sponsor
A Menarini Australia Pty Ltd
Artg Date
2015-05-01
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/874b3901aef8fc553b6b282b60fe2bed.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/6fa88fca4b024c8455cbfffc0abc72e8.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
67565aa4e27a3d7f
Type
Standard
Back to TGA Approvals